Search
  • Site Search
  • News
  • Product

    • Zhejiang Medical Technology Development Co., Ltd.

    Ipsen China and Zhejiang Medical announced conclusion of strategic cooperation agreement
    (Hangzhou, Zhejiang, China)-On December 12, 2017, Bofu-Ipsen (Tianjin) Pharmaceutical Co., Ltd. (hereinafter referred to as 'Ipsen China') and Zhejiang Medical Technology Development Co., Ltd. (hereinafter referred to as 'Zhejiang Medical') announced today that they had formally concluded a strategic cooperation agreement to promote Tanakan® in the Chinese market. This strategic cooperation is the beginning of mutual complementarity, information sharing and mutual benefit. With the signing of the strategic cooperation agreement, the two sides will further expand ...
    Ipsen China and Zhejiang Medical announced conclusion of strategic cooperation agreement
    Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. Established Strateg
    (November 2, 2017, Shanghai) Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. announced that they had concluded a strategic partnership agreement. Boehringer-Ingelheim China will grant exclusive authorization for the marketing of its respiratory drug Mucosolvan® injection to Zhejiang Medical Technology  Development Co., Ltd. (hereinafter Zhejiang Medical) from January 1, 2018. Boehringer-Ingelheim is still the owner and producer of Mucosolvan® injection.“We are very glad to establish strategic partnership with Zhejiang Medical....
    Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. Established Strateg
    Congratulate Zhejiang Zhejiang Medical Technology Development Co., Ltd. Becoming the Exclusive Agent
    Congratulate Zhejiang Medical Technology Development Co., Ltd. signing an agreement with Merz Germany. On October 27, 2017, Zhejiang Medical Technology Development Co., Ltd. and Merz Germany held an agreement signing ceremony for Contractubex in Wuxi, Jiangsu. Zhejiang Medical has officially become the exclusive agent of Contractubex in China.Contractubex® is the most popular scar treatment medicine around the world.Contractubex® has successfully been used to treat scars for more than 50 years. It is the scar treatment medicine sold best in over 60 countries and o...
    Congratulate Zhejiang Zhejiang Medical Technology Development Co., Ltd. Becoming the Exclusive Agent
    Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth
    On June 5, Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth Health Industrial Park in Xiacheng District, accompanied by the main leaders of the District Government Office, District Development and Reform Bureau, District Finance Bureau, District Health Planning Bureau, District Market Supervision Bureau, and Zhaohui Street Committee. Chai and his entourage first visited the functional areas of Winhealth Health Industrial Park, learned about the current industrial layout and development status of the park, then held a symposium to listen to a report made by the head o...
    Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth
    Zhejiang Medical and Kyowa Hakko Kirin signed sole agency agreement on Coniel®
    On May 9, 2017, Zhejiang Medical Technology Development Co., Ltd. under Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as 'WinHealth') and Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. (hereinafter referred to as 'Kyowa Hakko Kirin China') signed a 15-year exclusive agency agreement in Shanghai on Coniel®'s sales in China. The calcium channel blocker (CCB) is the first-line drug in the diagnosis and treatment guidelines for essential hypertension and angina pectoris in Europe, the United States, Japan and China. As a new type of CCB, Coniel&#...
    Zhejiang Medical and Kyowa Hakko Kirin signed sole agency agreement on Coniel®
    Award ceremony for 5-year-service employees of Winhealth
    Stand together for five years through storm and stress ——The award ceremony for the employees who have served Winhealth for five years was successfully held in Chengdong Park on April 24, 2017. Hu Qing, Chief Financial Officer of the company, Wang Qi, general manager of the Business Center, Zhang Xuedong, Chief Marketing Officer in the province, etc. attended the event, and presented trophies and gifts to the employees who have worked for the company for five years. Let's review the wonderful moments at the awards ceremony. The seasons change fast and 5 years have passed in a twinklin...
    Award ceremony for 5-year-service employees of Winhealth
    Join the trailwalk Winhealth is with you
    In order to celebrate the 11th anniversary of the establishment of Winhealth Group, enrich the cultural life of employees, promote mutual understanding among employees, strengthen team cohesion and teamwork, and express thanks to all employees for their hard work, the company specially launched a trailwalk, one of the series of activities for the celebration. The trailwalk started in Hangzhou Youth Activity Center on April 23, 2017. All the staff, who were well prepared and had high morale, headed for the finish line together! After the trailwalk started, the team led by Hu Qing, director...
    Join the trailwalk Winhealth is with you
    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline ）
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.
      网站地图
    浙ICP备12044547号
    Sitemap
    浙公网安备 33010302003458号